The present invention relates to a composition comprising SEQ ID NO:1 or 2 and one or more pharmaceutically acceptable carriers or diluents. The present invention further relates to the use of the composition as defined in claim 1 or SEQ ID NO:1 or 2 for the manufacture of a medicament for the treatment of neurodegenerative diseases. The present invention further relates to a method of treating neurodegenerative diseases.
